Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
VALIANTLAB Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Negative
Expensive and at a premium to industry median P/E
Weak price momentum
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Low ROE but improving trend
Low operating margin but improving trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
VALIANTLAB Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
VALIANTLAB Bulk, Block & Insider Trades
VALIANTLAB Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Rights issue
Rights issue(1 new shares @ 75 INR for 4 existing shares)"Rights ISIN INE0JWS20017CINS Y933BC122SEDOL BV2CZY9." Ex-date: 18th Jul 2025 Announced on: 15th Jul 2025
Company Profile
Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis,... Read More
Key personnel
Mr. Paresh Shashikant ShahD
Chief Financial Officer, Whole-Time Director
Akshay Gangurde
Compliance Officer, Company Secretary
Shri. Santosh Shantilal VoraD
Managing Director, Executive Director
Ms. Archana Dhanaji Koli
Purchase Manager
Mr. Chandrakant Mahadeo Mandhare
Head - Accounts and Finance
Ms. Kiran Mudaliar
Assistant Manager - Accounts
Mr. Bhanudas Devram Patil
Quality Control Manager
Mr. Nilesh Vinayak Patil
Head - Research and Development
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Valiant Laboratories Ltd.?
The current share price of Valiant Laboratories Ltd. is ₹ 67.43 as of 09 Jan 2026.
What is the PE ratio of Valiant Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Valiant Laboratories Ltd. is 2,836.81 as of the latest financial data.
What is the ROE and ROCE of Valiant Laboratories Ltd.?
Valiant Laboratories Ltd. has a Return on Equity (ROE) of -0.93% and a Return on Capital Employed (ROCE) of -2.02% as per the latest financial reports.
What is the market cap of Valiant Laboratories Ltd.?
The market capitalization of Valiant Laboratories Ltd. stands at ₹ 366.23 Cr.
What is the dividend yield of Valiant Laboratories Ltd.?
The dividend yield of Valiant Laboratories Ltd. is 0.00% based on the current market price.
What is the RSI of Valiant Laboratories Ltd.?
The Relative Strength Index (RSI) of Valiant Laboratories Ltd. is 41.91.
What is the FII and DII holding in Valiant Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.02% and Domestic Institutional Investors (DII) hold 0.00% of Valiant Laboratories Ltd. shares.
What sector does Valiant Laboratories Ltd. belong to?
Valiant Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Valiant Laboratories Ltd. stock?
The beta of Valiant Laboratories Ltd. stock is 0.95, indicating its volatility relative to the broader market.
